Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer

被引:110
作者
Polioudaki, Hara [1 ]
Agelaki, Sofia [2 ,3 ]
Chiotaki, Rena [1 ]
Politaki, Eleni [2 ]
Mavroudis, Dimitris [2 ,3 ]
Matikas, Alexios [3 ]
Georgoulias, Vassilis [2 ,3 ]
Theodoropoulos, Panayiotis A. [1 ]
机构
[1] Univ Crete, Sch Med, Dept Biochem, Iraklion, Greece
[2] Univ Crete, Sch Med, Lab Tumor Cell Biol, Iraklion, Greece
[3] Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
关键词
Circulating tumor cells; EMT; Breast cancer; Keratin expression levels; Fluorescence levels of cell markers; Vimentin/keratin ratio; EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELL; MICROTENTACLES; PATTERNS; MARKERS;
D O I
10.1186/s12885-015-1386-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: CTCs expressing variable levels of epithelial and mesenchymal markers in breast cancer have previously been reported. However, no information exists for keratin expression levels of CTCs in association with disease status, whereas assays for the characterization of transitional EMT phenotypes of CTCs in breast cancer are rather lacking. We investigated the correlation between keratin expression of CTCs and patients' outcome and characterized the EMT status of CTCs via the establishment of a numerical "ratio" value of keratin and vimentin expression levels on a single cell basis. Methods: Keratin expression was evaluated in 1262 CTCs from 61 CTC-positive patients with metastatic breast cancer, using analysis of images obtained through the CellSearch System. For the determination of vimentin/keratin (vim/K) ratios, expression levels of keratin and vimentin were measured in cytospin preparations of luminal (MCF-7 and T47D) and basal (MDA.MB231 and Hs578T) breast cancer cell lines and 110 CTCs from 5 CTC-positive patients using triple immunofluorescence laser scanning microscopy and image analysis. Results: MCF-7 and T47D displayed lower vim/K ratios compared to MDA.MB231 and Hs578T cells, while MCF-7 cells that had experimentally undergone EMT were characterized by varying intermediate vim/K ratios. CTCs were consisted of an heterogeneous population presenting variable vim/K values with 46% of them being in the range of luminal breast cancer cell lines. Keratin expression levels of CTCs detected by the CellSearch System correlated with triple negative (p = 0.039) and ER-negative (p = 0.025) breast cancer, and overall survival (p = 0.038). Conclusions: Keratin expression levels of CTCs correlate with tumor characteristics and clinical outcome. Moreover, CTCs display significant heterogeneity in terms of the degree of EMT phenotype that probably reflects differential invasive potential. The assessment of the vim/K ratios as a surrogate marker for the EMT status of CTCs merits further investigation as a prognostic tool in breast cancer.
引用
收藏
页数:10
相关论文
共 19 条
[1]   Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients [J].
Aktas, Bahriye ;
Tewes, Mitra ;
Fehm, Tanja ;
Hauch, Siegfried ;
Kimmig, Rainer ;
Kasimir-Bauer, Sabine .
BREAST CANCER RESEARCH, 2009, 11 (04)
[2]   Epithelial mesenchymal transition traits in human breast cancer cell lines [J].
Blick, T. ;
Widodo, E. ;
Hugo, H. ;
Waltham, M. ;
Lenburg, M. E. ;
Neve, R. M. ;
Thompson, E. W. .
CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 (06) :629-642
[3]   Triple-negative breast cancer: Clinical features and patterns of recurrence [J].
Dent, Rebecca ;
Trudeau, Maureen ;
Pritchard, Kathleen I. ;
Hanna, Wedad M. ;
Kahn, Harriet K. ;
Sawka, Carol A. ;
Lickley, Lavina A. ;
Rawlinson, Ellen ;
Sun, Ping ;
Narod, Steven A. .
CLINICAL CANCER RESEARCH, 2007, 13 (15) :4429-4434
[4]   Pattern of metastatic spread in triple-negative breast cancer [J].
Dent, Rebecca ;
Hanna, Wedad M. ;
Trudeau, Maureen ;
Rawlinson, Ellen ;
Sun, Ping ;
Narod, Steven A. .
BREAST CANCER RESEARCH AND TREATMENT, 2009, 115 (02) :423-428
[5]   Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal [J].
Gradilone, Angela ;
Raimondi, Cristina ;
Nicolazzo, Chiara ;
Petracca, Arianna ;
Gandini, Orietta ;
Vincenzi, Bruno ;
Naso, Giuseppe ;
Agliano, Anna Maria ;
Cortesi, Enrico ;
Gazzaniga, Paola .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2011, 15 (05) :1066-1070
[6]   Changes in Keratin Expression during Metastatic Progression of Breast Cancer: Impact on the Detection of Circulating Tumor Cells [J].
Joosse, Simon A. ;
Hannemann, Juliane ;
Spoetter, Julia ;
Bauche, Andreas ;
Andreas, Antje ;
Mueller, Volkmar ;
Pantel, Klaus .
CLINICAL CANCER RESEARCH, 2012, 18 (04) :993-1003
[7]   The basics of epithelial-mesenchymal transition [J].
Kalluri, Raghu ;
Weinberg, Robert A. .
JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (06) :1420-1428
[8]   The epithelial-mesenchymal transition generates cells with properties of stem cells [J].
Mani, Sendurai A. ;
Guo, Wenjun ;
Liao, Mai-Jing ;
Eaton, Elinor Ng. ;
Ayyanan, Ayyakkannu ;
Zhou, Alicia Y. ;
Brooks, Mary ;
Reinhard, Ferenc ;
Zhang, Cheng Cheng ;
Shipitsin, Michail ;
Campbell, Lauren L. ;
Polyak, Kornelia ;
Brisken, Cathrin ;
Yang, Jing ;
Weinberg, Robert A. .
CELL, 2008, 133 (04) :704-715
[9]   Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood [J].
Mikolajczyk, Stephen D. ;
Millar, Lisa S. ;
Tsinberg, Pavel ;
Coutts, Stephen M. ;
Zomorrodi, Maryam ;
Pham, Tam ;
Bischoff, Farideh Z. ;
Pircher, Tony J. .
JOURNAL OF ONCOLOGY, 2011, 2011
[10]   High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients [J].
Pierga, J. -Y. ;
Hajage, D. ;
Bachelot, T. ;
Delaloge, S. ;
Brain, E. ;
Campone, M. ;
Dieras, V. ;
Rolland, E. ;
Mignot, L. ;
Mathiot, C. ;
Bidard, F. -C. .
ANNALS OF ONCOLOGY, 2012, 23 (03) :618-624